IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 417.24 USD -0.31% Market Closed
Market Cap: 34.2B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

IDEXX Laboratories Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDEXX Laboratories Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
IDEXX Laboratories Inc
NASDAQ:IDXX
Net Change in Cash
-$23.1m
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Net Change in Cash
$375m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Net Change in Cash
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Change in Cash
$2B
CAGR 3-Years
N/A
CAGR 5-Years
131%
CAGR 10-Years
23%
Abbott Laboratories
NYSE:ABT
Net Change in Cash
-$848m
CAGR 3-Years
N/A
CAGR 5-Years
24%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Net Change in Cash
-$1.2B
CAGR 3-Years
-267%
CAGR 5-Years
-98%
CAGR 10-Years
-29%
No Stocks Found

IDEXX Laboratories Inc
Glance View

Market Cap
34.3B USD
Industry
Health Care

IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster their presence in both developed and emerging markets. For investors, IDEXX represents a compelling opportunity within a steadily growing sector. The company's recurring revenue model, driven by its suite of diagnostic tests and subscriptions to software solutions, ensures stable cash flow and predictability in earnings. IDEXX has also demonstrated impressive financial performance, characterized by strong revenue growth, high profit margins, and a commitment to shareholder returns. By harnessing trends in pet ownership and increasing expenditures on pet healthcare, IDEXX positions itself as a reliable player in the marketplace. With its dedication to innovation, customer service, and global expansion, IDEXX Laboratories Inc. stands poised for sustained growth, making it an attractive consideration for long-term investors.

IDXX Intrinsic Value
252.54 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is IDEXX Laboratories Inc's Net Change in Cash?
Net Change in Cash
-23.1m USD

Based on the financial report for Sep 30, 2024, IDEXX Laboratories Inc's Net Change in Cash amounts to -23.1m USD.

What is IDEXX Laboratories Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
12%

The average annual Net Change in Cash growth rates for IDEXX Laboratories Inc have been 9% over the past three years , 12% over the past five years .

Back to Top